PubMed

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R.

Diabetes. 2002 Oct;51(10):3090-4.PMID: 12351452 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice.

Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R.

Diabetes. 2004 Jan;53(1):166-72.PMID: 14693711 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.

Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.

Horm Metab Res. 2005 Jan;37(1):21-5.PMID: 15702434 [PubMed - indexed for MEDLINE]Related articles

Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.

Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A.

J Endocrinol. 2006 Mar;188(3):493-501.PMID: 16522729 [PubMed - indexed for MEDLINE]Related articlesFree article

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS.

Nephrol Dial Transplant. 2006 Feb;21(2):324-9. Epub 2005 Oct 25.PMID: 16249198 [PubMed - indexed for MEDLINE]Related articlesFree article

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.

Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.

Diabetes. 2006 May;55(5):1232-42.PMID: 16644677 [PubMed - indexed for MEDLINE]Related articlesFree article

Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S.

Br J Pharmacol. 2008 Jul;154(5):1025-34. Epub 2008 Apr 21.PMID: 18587447 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.PMID: 10859350 [PubMed - indexed for MEDLINE]Related articlesFree article

High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent.

Schrijvers BF, Rasch R, Tilton RG, Flyvbjerg A.

Kidney Int. 2002 May;61(5):1600-4.PMID: 11967009 [PubMed - indexed for MEDLINE]Related articlesFree article

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH.

Kidney Int. 2004 Jan;65(1):116-28.PMID: 14675042 [PubMed - indexed for MEDLINE]Related articles

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.

Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S.

J Am Soc Nephrol. 2006 Nov;17(11):3093-104. Epub 2006 Sep 20.PMID: 16988063 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

Kidney Int. 2005 Oct;68(4):1554-61.PMID: 16164632 [PubMed - indexed for MEDLINE]Related articles

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

FASEB J. 2000 Mar;14(3):439-47.PMID: 10698958 [PubMed - indexed for MEDLINE]Related articlesFree article

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.

de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH.

J Am Soc Nephrol. 2001 May;12(5):993-1000.PMID: 11316858 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of decline in renal function in the diabetic db/db mouse.

Cohen MP, Clements RS, Cohen JA, Shearman CW.

Diabetologia. 1996 Mar;39(3):270-4.PMID: 8721771 [PubMed - indexed for MEDLINE]Related articles

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):16-22.PMID: 12480514 [PubMed - indexed for MEDLINE]Related articles

Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.

Segev Y, Eshet R, Yakir O, Haim N, Phillip M, Landau D.

Diabetologia. 2007 Jun;50(6):1327-34. Epub 2007 Apr 19.PMID: 17443310 [PubMed - indexed for MEDLINE]Related articles

Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.

Cohen MP, Masson N, Hud E, Ziyadeh F, Han DC, Clements RS.

Exp Nephrol. 2000 May-Jun;8(3):135-43.PMID: 10810230 [PubMed - indexed for MEDLINE]Related articles

Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent.

Flyvbjerg A, Schrijvers BF, De Vriese AS, Tilton RG, Rasch R.

Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E362-6.PMID: 12110543 [PubMed - indexed for MEDLINE]Related articlesFree article